NCT02341105View on ClinicalTrials.gov

AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Catheter ablation

Pulmonary vein isolation by catheter ablation

DRUG

Amiodarone

antiarrhythmic therapy using Amiodarone

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences, Hamilton

Sponsors
All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

lead

Population Health Research Institute

OTHER